Southwest Airlines: Analyst Consensus Estimates For Q1 2021

Southwest Airlines (NASDAQ: LUV) will be reporting their first quarter results on April 22nd before the opening of markets. Analysts have a consensus $68.76 12-month price target on the company, via a total of 20 analysts, with five analysts having strong buy ratings. 11 analysts meanwhile have buy ratings and four analysts have hold ratings. The street high is an $80 price target, and the lowest target sits at $57 from Stifel.

12 analysts have revenue estimates for the first quarter. The mean between all 12 is $2.05 billion; this number has been revised downwards from $2.71 billion at the start of the year. The highest revenue estimate is $2.36 billion, while the lowest is $1.59 billion.

Onto EBITDA estimates, there are currently 7 analysts who have first-quarter EBITDA estimates. The mean is currently negative $979 million, with this number having been revised down from negative $286.86 million at the start of the year. Street high is a negative $718 million EBITDA estimate and the lowest being negative $1.4 billion.

Analysts estimate that quarterly earnings per share will come in at negative $1.86, with this number being revised down from negative $1 at the start of the year. Street high is negative $1.24 and the lowest estimate is negative $2.59 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Meghan Markle’s Half-Brother Submitted Evidence Against Their Father, But Now Faces Philippine Police Scrutiny

Related News

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Maxar Tech: Canaccord Lifts Target To US$42 Following Elevated Profile Due To Conflict

On April 12th, Canaccord Genuity raised their 12-month price target on Maxar Technologies (TSX: MAXR)...

Sunday, April 17, 2022, 05:18:00 PM

Tilray Sees Haywood Slash Price Target To $12.50

On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the...

Sunday, October 10, 2021, 04:49:00 PM

Were Traders Tipped Off About Maxar’s Buyout?

On December 16, Maxar Technologies (TSX: MAXR) announced that it would be acquired by Advent...

Friday, December 23, 2022, 06:24:00 AM

Canaccord Lowers Enthusiast Gaming’s Price Target Despite Prelim Earnings Beat

On February 8th, Enthusiast Gaming (TSX: EGLX) reported its preliminary fourth quarter 2021 results. The...

Thursday, February 17, 2022, 05:06:00 PM